Sihuan Pharmaceutical (00460.HK): New specification of skin booster injection (trade name: Dongyan) approved for marketing by the National Medical Products Administration

date
05/10/2026
Zhito Finance APP News, Sihuan Pharmaceutical (00460.HK) announced that five new specifications of the injectable sodium hyaluronate composite solution (skin booster or the product, trade name: Dongyan) independently developed by Meiyan Space Biotechnology (Jilin) Co., Ltd. (Meiyan Space), a subsidiary of the Group, have officially been approved for marketing by China's National Medical Products Administration. The approval of these new specifications marks an important post-launch milestone for the product, further strengthening the Group's product portfolio and competitiveness in the light medical aesthetics skin booster segment.